| Wockhardt Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532300 |
NSE Symbol : WOCKPHARMA |
P/E(TTM) : 156.69 |
|
ISIN Demat : INE049B01025 |
Div & Yield% : 0.00 |
EPS(TTM) : 8.68 |
|
Book Value(₹) : 177.62 |
Market Cap(₹Cr) : 22,100.56 |
Face Value(₹) : 5.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 380.00 | 413.00 | 355.00 | 325.00 | 370.00 | 352.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 380.00 | 413.00 | 355.00 | 325.00 | 370.00 | 352.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 30.00 | 25.00 | 14.00 | 6.00 | 11.00 | 27.00 |
| Total Income | 410.00 | 438.00 | 369.00 | 331.00 | 381.00 | 379.00 |
| Total Expenditure | 267.00 | 282.00 | 249.00 | 263.00 | 321.00 | 272.00 |
| PBIDT | 143.00 | 156.00 | 120.00 | 68.00 | 60.00 | 107.00 |
| Interest | 44.00 | 41.00 | 40.00 | 48.00 | 53.00 | 58.00 |
| PBDT | 99.00 | 115.00 | 80.00 | 20.00 | 7.00 | 49.00 |
| Depreciation | 45.00 | 46.00 | 40.00 | 42.00 | 43.00 | 43.00 |
| Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Reported Profit After Tax | 54.00 | 69.00 | 40.00 | -22.00 | -36.00 | 6.00 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 54.00 | 69.00 | 40.00 | -22.00 | -36.00 | 6.00 |
| EPS (Unit Curr.) | 3.26 | 4.25 | 2.47 | -1.40 | -2.34 | 0.39 |
| EPS (Adj) (Unit Curr.) | 3.26 | 4.25 | 2.47 | -1.40 | -2.34 | 0.39 |
| Calculated EPS (Unit Curr.) | 3.33 | 4.26 | 2.47 | -1.36 | -2.34 | 0.39 |
| Calculated EPS (Adj) (Unit Curr.) | 3.33 | 4.26 | 2.47 | -1.36 | -2.34 | 0.39 |
| Calculated EPS (Ann.) (Unit Curr.) | 13.33 | 17.04 | 9.88 | -5.43 | -9.35 | 1.56 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 13.33 | 17.04 | 9.88 | -5.43 | -9.35 | 1.56 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 81.00 | 81.00 | 81.00 | 81.00 | 77.00 | 77.00 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 | 5.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 37.63 | 37.77 | 33.80 | 20.92 | 16.22 | 30.40 |
| PBDTM(%) | 26.05 | 27.85 | 22.54 | 6.15 | 1.89 | 13.92 |
| PATM(%) | 14.21 | 16.71 | 11.27 | -6.77 | -9.73 | 1.70 |